These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19917750)

  • 1. VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae.
    Rodriguez-Martinez JM; Nordmann P; Fortineau N; Poirel L
    Antimicrob Agents Chemother; 2010 Jan; 54(1):471-6. PubMed ID: 19917750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.
    Poirel L; Naas T; Nicolas D; Collet L; Bellais S; Cavallo JD; Nordmann P
    Antimicrob Agents Chemother; 2000 Apr; 44(4):891-7. PubMed ID: 10722487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
    Yong D; Toleman MA; Giske CG; Cho HS; Sundman K; Lee K; Walsh TR
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5046-54. PubMed ID: 19770275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
    Robin F; Aggoune-Khinache N; Delmas J; Naim M; Bonnet R
    Antimicrob Agents Chemother; 2010 Jan; 54(1):466-70. PubMed ID: 19901092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDM-4 metallo-β-lactamase with increased carbapenemase activity from Escherichia coli.
    Nordmann P; Boulanger AE; Poirel L
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2184-6. PubMed ID: 22252797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First detection of a carbapenem-hydrolyzing metalloenzyme in two enterobacteriaceae isolates in Spain.
    Tórtola MT; Lavilla S; Miró E; González JJ; Larrosa N; Sabaté M; Navarro F; Prats G
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3492-4. PubMed ID: 16048967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates.
    Abbas HA; Kadry AA; Shaker GH; Goda RM
    Microb Pathog; 2019 Jul; 132():266-274. PubMed ID: 31096002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?
    Tato M; Coque TM; Ruíz-Garbajosa P; Pintado V; Cobo J; Sader HS; Jones RN; Baquero F; Cantón R
    Clin Infect Dis; 2007 Nov; 45(9):1171-8. PubMed ID: 17918078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China.
    Li Y; Li Q; Du Y; Jiang X; Tang J; Wang J; Li G; Jiang Y
    J Clin Microbiol; 2008 Apr; 46(4):1317-21. PubMed ID: 18305137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
    Cai JC; Zhou HW; Zhang R; Chen GX
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of the new metallo-beta-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae.
    Pournaras S; Poulou A; Voulgari E; Vrioni G; Kristo I; Tsakris A
    J Antimicrob Chemother; 2010 Aug; 65(8):1604-7. PubMed ID: 20522444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel VIM metallo-beta-lactamase variant, VIM-24, from a Klebsiella pneumoniae isolate from Colombia.
    Montealegre MC; Correa A; Briceño DF; Rosas NC; De La Cadena E; Ruiz SJ; Mojica MF; Camargo RD; Zuluaga I; Marin A; Quinn JP; Villegas MV;
    Antimicrob Agents Chemother; 2011 May; 55(5):2428-30. PubMed ID: 21282438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece.
    Galani I; Souli M; Mitchell N; Chryssouli Z; Giamarellou H
    Int J Antimicrob Agents; 2010 Sep; 36(3):252-4. PubMed ID: 20580536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of metallo-beta-lactamase VIM-27, an A57S mutant of VIM-1 associated with Klebsiella pneumoniae ST147.
    Papagiannitsis CC; Kotsakis SD; Petinaki E; Vatopoulos AC; Tzelepi E; Miriagou V; Tzouvelekis LS
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3570-2. PubMed ID: 21518835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
    Çakar A; Akyön Y; Gür D; Karatuna O; Öğünç D; Özhak Baysan B; Çöplü N; Çağatay M; Kılıç A; Baysallar M; Bakıcı Z; Çelik C; Gülay Z; Aydemir Ş; Tünger A; Kılıç H; Erçal BD; Aşçı Toraman Z; Zer Y; Büyüktaş A; Ay S; Aktaş Z; Kayacan Ç; Bayramoğlu G; Aydın F; Dündar D; Hasdemir U; Ayaş R; Yanık K; Günaydın M; Güdücüoğlu H; Parlak M
    Mikrobiyol Bul; 2016 Jan; 50(1):21-33. PubMed ID: 27058326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
    Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
    J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreaks in distinct regions due to a single Klebsiella pneumoniae clone carrying a bla VIM-1 metallo-{beta}-lactamase gene.
    Ikonomidis A; Tokatlidou D; Kristo I; Sofianou D; Tsakris A; Mantzana P; Pournaras S; Maniatis AN
    J Clin Microbiol; 2005 Oct; 43(10):5344-7. PubMed ID: 16208014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of carbapenem-resistant strains of Klebsiella pneumoniae isolated from Iranian patients: first identification of blaKPC gene in Iran.
    Nobari S; Shahcheraghi F; Rahmati Ghezelgeh F; Valizadeh B
    Microb Drug Resist; 2014 Aug; 20(4):285-93. PubMed ID: 24428238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
    Wachino J; Doi Y; Yamane K; Shibata N; Yagi T; Kubota T; Ito H; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1960-7. PubMed ID: 15155185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France.
    Naas T; Nordmann P; Vedel G; Poyart C
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4423-4. PubMed ID: 16189140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.